Requires DOC and county correctional facilities to provide certain inmates with medication-assisted treatment.
Impact
The bill has the potential to significantly impact state laws concerning the treatment of inmates. It stipulates that inmates who voluntarily agree to the treatment must have access to supportive services such as withdrawal management and behavioral health counseling. By formalizing medication-assisted treatment within correctional facilities, the bill promotes a shift towards rehabilitative care rather than punitive measures, thereby addressing the rising concern of substance use disorders within the prison population. The application of these services illustrates a broader movement towards addressing mental health and substance abuse issues in a more holistic manner.
Summary
Assembly Bill A3538 requires the New Jersey Department of Corrections (DOC) and county correctional facilities to provide medication-assisted treatment to inmates diagnosed with substance use disorders. This treatment begins with an evaluation upon the inmate's admission to determine their need for management of their condition. The bill outlines the types of medications that can be used, including approved drugs like naltrexone, methadone, and buprenorphine, complemented by counseling and behavioral therapies. This approach aims to provide a comprehensive treatment strategy for individuals struggling with substance-related issues while incarcerated.
Contention
Although A3538 is aimed at improving the welfare of inmates with substance use disorders, it may face contention around practical implementation and resource allocation. Critics may argue about the feasibility of the required evaluations and treatments, particularly in under-resourced correctional facilities. Additionally, there could be debates regarding the efficacy of medication-assisted treatment and the potential stigma associated with providing such treatment in correctional facilities. Advocates for mental health may support the bill as a necessary progression towards compassion in correctional health but will likely continue advocating for robust oversight and funding to ensure its success and sustainability.
Imposes requirements on video visitation service contracts for inmates in certain correctional facilities; requires correctional facilities to allow contact visits.
Imposes requirements on video visitation service contracts for inmates in certain correctional facilities; requires correctional facilities to allow contact visits.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.